Stock Updates

A look at a High Market Cap Stock: Boston Scientific Corporation, BSX

Boston Scientific Corporation, BSX is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Boston Scientific Corporation, BSX  has a market cap of 32157.82. Since its IPO date on the 5/19/1992, Boston Scientific Corporation, BSX performance year to date is 28.52%. Today Boston Scientific Corporation, BSX has gained 0.72%, with a current price of 23.87.

Ownership of the company is 0.50% for insider ownership while institutional ownership is 95.50%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at -0.20%, with return on investment at 0.70%.

In terms of debt levels and profit levels, Boston Scientific Corporation, BSX is seeing a long-term debt/equity of 0.84. While Total debt/equity is 0.88. With a profit margin of -0.50%, this is combined with a gross margin of 71.40%, and operating margin of -0.80%. Boston Scientific Corporation ability to meet debt levels, with a current ratio of 1.2, while the quick ratio is 0.8.

For the last year Boston Scientific Corporation, BSX has seen a EPS growth of -98.30%. A performance for the year of 36.52%. The 52-week high is -2.37%, and the 52-week low is 68.34%. The average volume for Boston Scientific Corporation, BSX is 3844290.

With a target price of 24.89, can Boston Scientific Corporation, BSX reach this target? Looking at the value indicators of Boston Scientific Corporation, BSX. Boston Scientific Corporation has a P/E of *TBA and a forward P/E of 19.21. Perhaps the more useful indicator than P/E, is PEG which has a value of *TBA. Boston Scientific Corporation also has a P/S and a P/B of 4.19 and 4.96 respectively. For P/cash, Boston Scientific Corporation has a value of 95.14, while it is 82.88 for P/free cash flow.

At the current price of 23.87, Boston Scientific Corporation has a dividend yield of *TBA. We see a return on equity of -0.60%.

Looking more long-term Boston Scientific Corporation, is projected to get an EPS growth for the next five years of 12.70%. In the short-term an EPS growth of 13.00% in the next year is forecasted. This is after a EPS growth of -98.30% for this year and for the last five years a 24.00% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment